Dyne Therapeutics, Inc. EV/EBITDA

EV/EBITDA of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.

Highlights and Quick Summary

Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Dyne Therapeutics, Inc.

Most recent EV/EBITDAof DYN including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Dyne Therapeutics, Inc.

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com